TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16784587

Group type: EXPERIMENTAL
Intervention: Electronic dental analgesia (EDA) device - Team Up Duo (active state)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Electronic dental analgesia (EDA) device - Team Up Duo (inactive state)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Electronic dental analgesia (EDA) device - Team Up Duo
Number of subjects: 81
Study: 15254561

Group type: EXPERIMENTAL
Intervention: Antenatal magnesium sulfate exposure during preterm labor
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 140
Study: 11084272

Group type: EXPERIMENTAL
Intervention: Phaco-chop
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stop-and-chop
Number of subjects: 40
Study: 8816209

Group type: EXPERIMENTAL
Intervention: Two aliquots of surfactant
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Six aliquots of surfactant
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surfactant instillation (both groups)
Number of subjects: 20
Study: 1446992

Group type: EXPERIMENTAL
Intervention: Flunarizine (Fz) 10 mg/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 4076324

Group type: EXPERIMENTAL
Intervention: Dimalan
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Maalox
Number of subjects: 12

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 12
Study: 31524938

Group type: EXPERIMENTAL
Intervention: Adding diabetes medications; 410 participants rated importance of 7 factors.
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Stopping diabetes medications; 408 participants rated importance of 7 factors.
Number of subjects: 818
Study: 28601716

Group type: EXPERIMENTAL
Intervention: Anxiety evaluated by Hospital Anxiety and Depression Scale-anxiety subscale at baseline.
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Anxiety evaluation in ACS patients.
Number of subjects: 828
Study: 26052565

Group type: EXPERIMENTAL
Intervention: CABG with BMMNC transplantation
Number of subjects: 42

Group type: COMPARATOR
Intervention: CABG only
Number of subjects: 42
Study: 23970305

Group type: EXPERIMENTAL
Intervention: ω3 polyunsaturated fatty acid enriched lipid emulsion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Soybean oil
Number of subjects: 14
Study: 21558567

Group type: EXPERIMENTAL
Intervention: Strength training (TG; twice per week for 12 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 20137540

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/d) and probucol (500 mg/d) for 4 weeks (combination group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Atorvastatin (20 mg/d) for 4 weeks (atorvastatin group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Atorvastatin and combination)
Number of subjects: 30
Study: 16316886

Group type: EXPERIMENTAL
Intervention: Tailored hypnotic induction
Number of subjects: 8

Group type: COMPARATOR
Intervention: Manualized hypnotic induction (Palsson's protocol)
Number of subjects: 8
Study: 15232805

Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask airway
Number of subjects: 86

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 86
Study: 11575866

Group type: EXPERIMENTAL
Intervention: Rasagiline (0.5, 1, and 2 mg/d)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9059469

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CPAP therapy (for patients with best CPAP use)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CPAP therapy (compliance comparison)
Number of subjects: 16
Study: 7903218

Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Propranolol 160 mg (SR)
Number of subjects: 17
Study: 3898795

Group type: EXPERIMENTAL
Intervention: Intravenous timolol
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 3169487

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups (indomethacin and control)
Number of subjects: 23
Study: 29860473

Group type: EXPERIMENTAL
Intervention: Macimorelin (single-dose oral)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Insulin tolerance test (ITT)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Macimorelin (retesting)
Number of subjects: 139
Study: 28270180

Group type: EXPERIMENTAL
Intervention: Active acupressure therapy (PC6, LI4, HT7 acupressure performed three times a day for 2 days)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Light touch (sham acupressure, performed three times a day for 2 days)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no visit)
Number of subjects: 150
Study: 26009822

Group type: EXPERIMENTAL
Intervention: Subjective evaluation of sublingual microcirculation images by physicians and nurses
Number of subjects: 106
Study: 23534046

Group type: EXPERIMENTAL
Intervention: Fluorinex treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (untreated teeth)
Number of subjects: 20
Study: 21636013

Group type: EXPERIMENTAL
Intervention: Vitamin B₆ intake (median daily intake of 0.9 mg/day, range 0.6-1.5 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study: 18499601

Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 40
Study: 16595616

Group type: EXPERIMENTAL
Intervention: Levosimendan (24 microg kg(‐1) infused i.v. over a 10 min period)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 14663295

Group type: EXPERIMENTAL
Intervention: Exercise training (ET) for 6 months
Number of subjects: 73
Study: 10891912

Group type: EXPERIMENTAL
Intervention: Naratriptan 1.5 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 8838506

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients receiving low dose methotrexate (MTX)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Rheumatoid arthritis (RA) patients not receiving low dose methotrexate (MTX)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Controls (healthy individuals), n = 26
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients with positive serum tests for RF
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients with HLA‐DR4 positive genotype
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA) patients overall
Number of subjects: 26
Study: 1486071

Group type: EXPERIMENTAL
Intervention: 0.3% ofloxacin solution
Number of subjects: 104

Group type: COMPARATOR
Intervention: 0.3% gentamicin ophthalmic solution
Number of subjects: 104
Study: 3988433

Group type: EXPERIMENTAL
Intervention: Self-learning packages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Small group seminars
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lectures
Number of subjects: 0
Study: 30191262

Group type: EXPERIMENTAL
Intervention: Laquinimod (0.6 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Combined oral contraceptives (COC)
Number of subjects: 48
Study: 29526474

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 27210427

Group type: EXPERIMENTAL
Intervention: GS-4774 2 YU
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: GS-4774 10 YU
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: GS-4774 40 YU
Number of subjects: 178

Group type: COMPARATOR
Intervention: OAV alone (Control)
Number of subjects: 178
Study: 25515217

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention for CVD risk management including electronic decision support, patient risk communication tools, computerized audit and feedback tools, and monthly peer-ranked performance feedback via a web portal.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention for CVD risk management.
Number of subjects: 60
Study: 22835059

Group type: EXPERIMENTAL
Intervention: Group C (Cell Saver 5+)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group M (autolog)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group F (CATS)
Number of subjects: 30
Study: 20174803

Group type: EXPERIMENTAL
Intervention: Total Thyroidectomy (TT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Dunhill operation (DO)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Bilateral Subtotal Thyroidectomy (BST)
Number of subjects: 600
Study: 17196208

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400mg TID for 6 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 64
Study: 15948681

Group type: EXPERIMENTAL
Intervention: HF-DDS graft
Number of subjects: 13

Group type: COMPARATOR
Intervention: CTG
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: HF-DDS (single thickness)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: HF-DDS and CTG
Number of subjects: 13
Study: 11443558

Group type: EXPERIMENTAL
Intervention: M. bovis BCG vaccination
Number of subjects: 616

Group type: COMPARATOR
Intervention: Control group (no BCG vaccination)
Number of subjects: 616
Study: 9570608

Group type: EXPERIMENTAL
Intervention: 0.06% bupivacaine with sufentanil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.12% bupivacaine with sufentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: sufentanil alone
Number of subjects: 60
Study: 7985829

Group type: EXPERIMENTAL
Intervention: 10 g fish oil (group A)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 10 g placebo Italian olive oil (group B)
Number of subjects: 39
Study: 2658392

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at night
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31814599

Group type: EXPERIMENTAL
Intervention: HPV analysis in heavy smokers
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HPV types 6 and 16
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HPV infections in pre-neoplastic conditions versus cancer
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smoking and alcohol consumption
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Advanced T stage
Number of subjects: 60
Study: 29071755

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender essential oil
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study: 26093363

Group type: EXPERIMENTAL
Intervention: Intensive periodontal disease treatment during mid-pregnancy (20-28 weeks' gestation)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (same treatment postnatally)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intensive periodontal disease treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Severity of periodontal disease
Number of subjects: 80
Study: 24434527

Group type: EXPERIMENTAL
Intervention: Bupropion 150 mg/d as an open-label add-on therapy (n = 5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Previous treatment (valproate and aripiprazole) without bupropion (n = 7)
Number of subjects: 12
Study: 23031335

Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment for 3 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined alpha/beta-blocker treatment for 3 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study: 19250152

Group type: EXPERIMENTAL
Intervention: Online cognitive behavioural therapy (CBT)
Number of subjects: 24
Study: 17502744

Group type: EXPERIMENTAL
Intervention: balafilcon A
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: lotrafilcon A
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: no lens wear
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: etafilcon A
Number of subjects: 25

Group type: COMPARATOR
Intervention: senofilcon A
Number of subjects: 25
Study: 15007010

Group type: EXPERIMENTAL
Intervention: Exercise training (20 minutes of bicycle ergometry per day for 12 months)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard percutaneous coronary intervention (PCI) with stenting
Number of subjects: 101
Study: 11529364

Group type: EXPERIMENTAL
Intervention: Kenacort‐A injection into the right tonsillar fossa
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (left side, no intervention)
Number of subjects: 50
Study: 9738383

Group type: EXPERIMENTAL
Intervention: ICCE with AC IOL
Number of subjects: 2000

Group type: COMPARATOR
Intervention: ICCE with aphakic correction (control group)
Number of subjects: 2000
Study: 8109906

Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A (botox)
Number of subjects: 2
Study: 2732408

Group type: EXPERIMENTAL
Intervention: Sulfite-treated lettuce (sodium bisulfite freshener)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (lettuce treated with freshener containing no sulfite)
Number of subjects: 5
Study: 30106532

Group type: EXPERIMENTAL
Intervention: Toothpaste with Novamin (1,426 ppmF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control toothpaste (1,450 ppmF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Toothpaste with Arginine and calcium carbonate (1,450 ppmF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All tested dentifrices
Number of subjects: 10
Study: 28089149

Group type: EXPERIMENTAL
Intervention: Early eptifibatide
Number of subjects: 2240

Group type: COMPARATOR
Intervention: Delayed, provisional use of eptifibatide
Number of subjects: 2240

Group type: EXPERIMENTAL
Intervention: Fasting glucose
Number of subjects: 2240

Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 2240
Study: 26122726

Group type: EXPERIMENTAL
Intervention: Biosimilar filgrastim (EP2006)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Reference filgrastim (Neupogen)
Number of subjects: 218
Study: 23515949

Group type: EXPERIMENTAL
Intervention: Gadofosveset trisodium (MS-325; Lantheus Med, 0.03 mmol/Kg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Gadobenate dimeglumine (Gd-BOPTA; Bracco, 0.1 mmol/Kg)
Number of subjects: 22
Study: 21872998

Group type: EXPERIMENTAL
Intervention: Varenicline with flexible quit date (FQD) approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Varenicline with target quit date (TQD) approach
Number of subjects: 0
Study: 19752608

Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine gel and 5 ml bupivacaine (0.25%) injected into periprostatic area
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intrarectal lidocaine gel and 5 ml ropivacaine (0.25%) injected into periprostatic area
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intrarectal lidocaine gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 100
Study: 17697548

Group type: EXPERIMENTAL
Intervention: TACE plus thalidomide (200 mg/d for 1-6 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 108
Study: 14973801

Group type: EXPERIMENTAL
Intervention: Intravenous iron supplementation with iron III‐hydroxide sucrose complex (IHSC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: IV iron and a single dose of r‐HuEPO (300 U/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study: 11214126

Group type: EXPERIMENTAL
Intervention: 1500 mg sulphate oral glucosamine once daily for 3 years
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo once daily for 3 years
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 8783377

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS)
Number of subjects: 48
Study: 2272187

Group type: EXPERIMENTAL
Intervention: Controlled-release indomethacin (75 mg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sustained-release diclofenac sodium (100 mg)
Number of subjects: 84
Study: 6937788

Group type: EXPERIMENTAL
Intervention: 100 ml cows' milk (double-blind challenge)
Number of subjects: 23
Study: 31104033

Group type: EXPERIMENTAL
Intervention: Customized FRC post with 37% H3PO4 etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Customized FRC post with 19% EDTA etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Customized FRC post with control etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Root canal reshaping with 37% H3PO4 etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Root canal reshaping with 19% EDTA etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Root canal reshaping with control etching
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study: 28502735

Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (LCD; 1.25mmol/L)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard calcium dialysate (SCD; 1.5mmol/L)
Number of subjects: 76
Study: 25664556

Group type: EXPERIMENTAL
Intervention: Parent functioning related to diabetes care
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Parent mealtime behaviors
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Diabetes-specific parent functioning
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Child mealtime behaviors
Number of subjects: 134
Study: 24662009

Group type: EXPERIMENTAL
Intervention: whole-body periodic acceleration (pGz)
Number of subjects: 17

Group type: COMPARATOR
Intervention: control group
Number of subjects: 17
Study: 22483238

Group type: EXPERIMENTAL
Intervention: Taeumjowi-tang (TJ001) 7 g three times daily for 12 weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Taeumjowi-tang (TJ001)
Number of subjects: 104
Study: 20400000

Group type: EXPERIMENTAL
Intervention: Nasal oxygen administration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no nasal oxygen)
Number of subjects: 30
Study: 18074413

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg once a day
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg two times a day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no hypoglycemic treatment)
Number of subjects: 90
Study: 15651718

Group type: EXPERIMENTAL
Intervention: Right infra-axillary minithoracotomy (Group A; n = 29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Conventional median sternotomy (Group B; n = 30)
Number of subjects: 59
Study: 11961623

Group type: EXPERIMENTAL
Intervention: Structured training methods (MIST-VR)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Structured training methods (Box trainer drills)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Structured training methods (four groups)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MIST-VR tasks
Number of subjects: 43
Study: 10408729

Group type: EXPERIMENTAL
Intervention: MN rgp120 HIV-1 vaccine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: IIIB rgp120 HIV-1 vaccine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MN rgp120 HIV-1 vaccine (booster)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MN and IIIB rgp120 HIV-1 vaccines (coadministered)
Number of subjects: 25
Study: 8900242

Group type: EXPERIMENTAL
Intervention: Met-985 insulin-receptor variant
Number of subjects: 699

Group type: COMPARATOR
Intervention: Normal oral glucose tolerance test
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Met-985 carriers
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Total study group analysis
Number of subjects: 699
Study: 19186427

Group type: EXPERIMENTAL
Intervention: Copal varnish before the retrofill amalgam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Copal varnish before and after the retrofill amalgam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Barrier (polyamide varnish) before the retrofill amalgam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Barrier before and after the retrofill amalgam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Retrofill amalgam with no varnish
Number of subjects: 60
Study: 6143187

Group type: EXPERIMENTAL
Intervention: 0.1 ml intradermally at 8 sites
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Various regimens (including multiple sites intradermally or subcutaneously)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 8-site intradermal vaccination with large dose of HRIG
Number of subjects: 98
Study: 30365961

Group type: EXPERIMENTAL
Intervention: CPB flow rate of 2.4 L · min‐1 · m‐2
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CPB flow rate of 2.7 L · min‐1 · m‐2
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CPB flow rate of 3.0 L · min‐1 · m‐2
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CPB flow rates of 2.4, 2.7, and 3.0 L · min‐1 · m‐2
Number of subjects: 17
Study: 30285672

Group type: EXPERIMENTAL
Intervention: Transdiagnostic group cognitive-behaviour therapy (tCBT) - 12 weekly 2-hour group sessions following a manualized treatment protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) for anxiety disorders
Number of subjects: 0
Study: 26948161

Group type: EXPERIMENTAL
Intervention: GUM (chewing gum for 15min per hour over 3 hours)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GUM
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no gum)
Number of subjects: 50
Study: 24597608

Group type: EXPERIMENTAL
Intervention: Fast-track surgery combined with laparoscopy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional perioperative intervention plus laparoscopy
Number of subjects: 120
Study: 22647453

Group type: EXPERIMENTAL
Intervention: Morphology plus NIR spectroscopy of embryo culture medium
Number of subjects: 417

Group type: COMPARATOR
Intervention: Morphology only (control group)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Embryos with best morphology (selected by embryological technician)
Number of subjects: 417